Chesnara good performance analysed by Dr Brian Moretta (Analyst VIDEO)

Chesnara plc (LON:CSN) is the company of discussion when Dr Brian Moretta, Analyst at Hardman & Co joins DirectorsTalk Interviews.

In this interview Brian explains how the company performed over the full year, discusses the operational challenges, updates us on the dividend, progress with its acquisition strategy and immediate prospects.

Chesnara is an established Life and Pensions Consolidator in the UK and Europe. The company focuses on delivering value to customers and shareholders through three strategic pillars: maximising the value from existing business, acquiring life and pensions businesses and enhancing value through profitable new business.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Hardman & Co

    More articles like this

    Hardman & Co

    Chesnara: Market benefits overwhelm operational challenges

    Chesnara plc (LON:CSN) has announced its 2021 full-year results. The headline figures are good, with Economic Value earnings of £57.8m. Within this, there were strong positive results from economic variances. Operational variances showed the effect of the challenges

    Hardman & Co

    Chesnara: Could be the least worrying dividend you’ll get

    Life assurance consolidators should be boring most of the time, perhaps apart from when they do some M&A. Operationally, Chesnara Plc (LON:CSN) has been close to achieving that, although recent events have made it challenging. Although cash generation